Cargando…
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
Sarcomas constitute a rare heterogeneous group of tumors, including a wide variety of histological subtypes. Despite advances in our understanding of the pathophysiology of the disease, first-line sarcoma treatment options are still limited and new treatment approaches are needed. Histone H2AX phosp...
Autores principales: | Perez, Marco, García-Heredia, José Manuel, Felipe-Abrio, Blanca, Muñoz-Galván, Sandra, Martín-Broto, Javier, Carnero, Amancio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508862/ https://www.ncbi.nlm.nih.gov/pubmed/32963243 http://dx.doi.org/10.1038/s41392-020-00246-z |
Ejemplares similares
-
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016) -
MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
por: Rivero, Maria, et al.
Publicado: (2018) -
The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
por: García-Heredia, José M., et al.
Publicado: (2017) -
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
por: Felipe-Abrio, Blanca, et al.
Publicado: (2020) -
c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019)